An explanatory sequential investigation of the working alliance as a change process in videoconferencing psychotherapy by Norwood, Carl et al.
Biosensors and Bioelectronics 177 (2021) 113002
Available online 16 January 2021
0956-5663/© 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Carboxyl-fentanyl detection using optical fibre grating-based sensors 
functionalised with molecularly imprinted nanoparticles 
LiangLiang Liu a,1, Fabiana Grillo c,1, Francesco Canfarotta b, Michael Whitcombe c, 
Stephen P. Morgan a, Sergey Piletsky c, Ricardo Correia a, ChenYang He a, Andrew Norris d,e, 
Serhiy Korposh a,* 
a Optics and Photonics Group, University of Nottingham, Nottingham, UK 
b MIP Diagnostics Ltd, Bedford, UK 
c Department of Chemistry, University of Leicester, Leicester, UK 
d Department of Anesthesiology, Nottingham University Hospitals NHS Trust, Nottingham, UK 
e Department of Anesthesiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia   
A R T I C L E  I N F O   
Keywords: 
Fentanyl 
Optical fibre long period grating 
Molecular imprinting 
A B S T R A C T   
Butyrylfentanyl is a new designer drug reported with growing use and related deaths. Routine toxicological 
analyses of this novel synthetic opioid drug have not been established yet. This work reports a fibre optic sensor 
that measures carboxyl-fentanyl which is the major metabolite of butyrylfentanyl presented in blood, providing a 
promising tool for detecting butyrylfentanyl intoxication. A long period fibre grating (LPG) sensor array oper-
ating at phase-matching condition is deployed in combination with a state-of-the-art molecular imprinting 
technique. Nano-sized molecularly imprinted polymers (nanoMIPs) are synthesised via a solid-phase approach 
and coated on the surface of an LPG array. An LPG array consists of two parts: a detection and a reference LPG. 
The former is functionalised with nanoMIPs prior to the measurements, whilst the latter is used to take into 
account the temperature response of the detection LPG. The developed sensor exhibits a gradual response over 
increasing concentrations of carboxyl-fentanyl from 0 to 1000 ng/mL with a minimal detected concentration of 
50 ng/mL, that corresponds to a wavelength shift of 1.20 ± 0.2 nm. The Langmuir adsorption isotherm is applied 
to fit the analytical data which reveal a binding constant of 2.03 μM-1. The developed sensor shows high 
selectivity in detecting carboxyl-fentanyl among other drugs and potential interferents including morphine, 
cocaine, glucose and albumin. It shows a certain degree of cross-response to fentanyl which shares the same 
binding sites as carboxyl-fentanyl and therefore can be potentially used to detect fentanyl.   
1. Introduction 
The interest in drug detection is increasing due to high demand in 
sporting competitions and police investigations. According to the United 
Nations Office on Drugs and Crime, nearly five percent of the global 
adult population regularly consumed prohibited drugs (world drug 
report 2015, UNODC). 
Opioid-related deaths have been reported worldwide as the biggest 
contributor to drug-related deaths (66% of drug deaths in 2017) (Rubin, 
2017; Kimber et al., 2019) where both prescription and non-prescription 
(illicit) opioid are responsible for these deaths. Repeated warnings were 
emitted by the EMCDDA particularly in relation to fentanyl diffusion in 
different areas of Europe as well as the presence of new formulations of 
fentanyl analogues, with some of them up to 10,000 times more potent 
than morphine (O’Donnell et al., 2017). 
In addition to the already known and scheduled substances, new 
psychoactive substances are continuously being brought to the market, 
rising serious worries as their pharmacological and toxicological effects 
are mostly unknown (A and European Drug Repo, 2017), in addition to 
the lack of routine testing in standard toxicology analysis (Oldenhof 
et al., 2020). 
Between 2012 and 2017, more than a dozen additional fentanyl 
analogues have entered the illicit opioid market. Some of these ana-
logues have been re-discovered by traffickers from research work 
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carried out between the 1960s and 1990s. These substances were 
described in the scientific literature, but never developed into pharma-
ceutical products. Examples include acetylfentanyl, butyrfentanyl, fur-
anylfentanyl, and ocfentanil (Crime, 2017). 
Butyrylfentanyl is an analogue of fentanyl with an N-butyryl group 
replacing the N-propionyl group of fentanyl (modified fentanyl). It is a 
novel synthetic opioid as a substitute for prescription opioid with po-
tency seven times that of morphine and 0.13 time of fentanyl (Armenian 
et al., 2018), temporarily scheduled as Schedule I substance under the 
Controlled Substances Act in 2016 (Drug Enforcement Administ, 2016). 
It is not approved for medical use, but it is being used for recreational 
purpose with cases of fatal overdoses reported (Le and Alzghari, 2019). 
As most of the designer drugs, the actual extent of abuse and mortality 
associated with butyrylfentanyl is not known due to the lack of routine 
toxicological analyses (Organization, 2016). 
The metabolism of butyrylfentanyl is studied by Steuer et al. with 
authentic blood and urine samples from a fatal intoxication case. It re-
veals that hydroxylation of the butanamide side chain followed by 
oxidation to the carboxylic acid is the major metabolic pathway of 
butyrylfentanyl in vivo (Steuer et al., 2017). A similar conclusion is 
drawn by Staeheli et al. who concluded that carboxyl-fentanyl is iden-
tified as one of the two most abundant metabolites (Staeheli et al., 
2016). It is therefore, of great interest to detect carboxyl-fentanyl in 
blood samples to determine intoxication of butyrylfentanyl, especially 
considering that the misuse of novel synthetic opioids, including 
butyrylfentanyl, has become a new deadly trend epidemically (Prekupec 
et al., 2017). The global drugs of abuse testing market in 2017 has been 
evaluated at $4,443.9 million by the United Nations Office on Drugs and 
Crime (Drugs of Abuse Testing Ma, 2018), and is estimated to swell up to 
$6,781.6 million by 2025. This highlights a rising need for reliable, 
quick, and robust methods of detection for drugs of abuse (Shaw and 
Dennany, 2017; Campuzano et al., 2018; Wren et al., 2014). The current 
developed methods to measure fentanyl or fentanyl-analogues such as 
gas-liquid chromatography (Kowalski et al., 1987), surface-enhanced 
Raman spectroscopy (Haddad et al., 2018), thermal desorption direct 
analysis based on real time mass spectrometry (TD-DART-MS) and ion 
mobility spectrometry (IMS) (Sisco et al., 2017). Despite the fact that 
these techniques have successfully been applied in many laboratories, 
this technology is not always readily available for real time routine 
police checks and often requires technical expertise. The instruments 
also cannot be scaled down into a portable device for in situ detection in 
forensic or real time detection for medical purposes. In parallel to the 
quantitative methods just described, semi-quantitative methods have 
been used in hospitals as routine urine toxicology screens using 
enzyme-mediated immunoassays such as enzyme linked immunosorbent 
assay (ELISA) (Tiscione and Wegner, 2017; Wang et al., 2011) and 
radioimmunoassay (Michiels et al., 1977). However, despite the many 
advantages, numerous well-known disadvantages need to be considered 
when immunological/enzymatic elements are involved. Refrigeration is 
required for transport and storage, and the production of antibodies is 
characterised by a long manufacture period, 6–9 weeks in the case of 
polyclonal antibodies and cost is a further problem to consider (Leenaars 
and Hendriksen, 2005). Ultimately, because of these issues, neither mass 
spectroscopy nor immunoassays are ideal for real time blood monitoring 
in clinical applications, or for in situ forensic tests. It would therefore be 
beneficial to develop a low cost, easy to use, point of care sensor. 
Molecularly imprinted polymeric nanoparticles (nanoMIPs) have 
proven to be a valid alternative to antibodies (Vlatakis et al., 1993) in 
numerous diagnostic techniques such as enzyme-linked and fluoro-
metric assays for a large variety of analytes (Chianella et al., 2013; 
Piletsky et al., 2017; Smolinska-Kempisty et al., 2017). NanoMIPs offer 
numerous advantages when compared with antibodies, notably their 
ability to bind small molecules, which are often not immunogenic 
(Wadhwa et al., 2015). Interest in nanoMIPs is growing rapidly due to 
the ability to imprint a large variety of chemically and structurally 
different molecules (Piletska et al., 2004; Kamra et al., 2015; 
Chantada-Vázquez et al., 2016), as well as complex structures such as 
proteins (Guerreiro et al., 2014; Pluhar et al., 2015). 
Optical fiber sensors (OFS) can be miniaturised, produced at low 
cost, can be suitable for remote sensing, have multiplexing capability 
and are immune to electromagnetic interference. OFS are popular in 
sensing of biochemical analytes such as glucose (Shukla et al., 2017), 
bacteria (Slavık et al., 2002), antibodies (Liu et al., 2018) and DNA 
(Huang et al., 2015) owing to their high sensitivity. The ability of 
label-free detection is one of the distinctive features of OFS, and optical 
fiber-based surface Plasmon resonance (SPR) (Wang et al., 2017), lossy 
mode resonance (LMR) (Chiavaioli et al., 2018) and optical grating 
sensors (Liu et al., 2018) are popular label-free detection techniques that 
detect biomolecular interaction via change of surface refractive index 
(RI). An optical fiber long period grating (LPG) sensor has a selected 
electric field coupled from the fundamental core mode into the fiber 
cladding, and the extended electric field renders sensitivity to refractive 
index wherein resonance wavelengths of an LPG sensor change corre-
spondingly. The response to RI change can be explained as: 
λi = [ncore − nclad(i)]Λ (1)  
Where the ncore and nclad(i) are the effective refractive indexes of fibre 
core and ith cladding mode; Λ is the grating period of LPG sensor. A 
change of surrounding refractive index essentially alters the nclad(i)
value, and as a result, the resonance wavelengths λi changes. 
This work reports, to our knowledge, the first demonstration of an 
optical fibre sensor for detection of carboxyl-fentanyl. An LPG sensor is 
functionalised with nanoMIPs for detection of carboxyl-fentanyl in 
aqueous solution. A state-of-art molecular imprinting technique is 
deployed for producing nanoMIPs that selectively capture carboxyl- 
fentanyl on the surface of the functionalised LPG sensor. The LPG 
sensor of selected grating period operates at the phase matching con-
dition near the visible wavelength range providing high RI sensitivity 
and a reference LPG is used to compensate temperature cross-sensitivity. 
Such a sensor array configuration addresses a common limit of single 
LPG sensors that is their strong dependence on temperature variations in 
the environment. The reported sensor shows high selectivity to 
carboxyl-fentanyl, is able to detect fentanyl (due to identical binding 
sites to carboxyl-fentanyl), negligible response to other tested drugs (i.e. 
cocaine and morphine) or substances present in blood (glucose and 
albumin). 
2. Result and discussion 
2.1. NanoMIPs characterisation 
After synthesis, the nanoMIPs are dialysed in distilled water using 
dialysis membranes (SnakeSkin™ Dialysis Tubing, 10K MWCO, 22 mm) 
and concentrated down to 0.67 mg/ml, and this stock was used for all 
subsequent tests. The size distribution of the nanoMIPs was charac-
terised via Dynamic Light Scattering (DLS, Fig.S.1), which showed an 
average hydrodynamic diameter of 171 ± 2 nm. 
The nanoMIPs contain methacrylic acid, therefore they bear carboxyl 
groups that can be exploited for immobilisation on the optical fibre 
(functionalised with primary amine groups) via EDC/NHS coupling. 
Fig. 1 shows the SEM image of nanoMIPs after immobilisation on the 
optical fibre. The nanoMIPs show spherical shape with variable sizes 
around 100 nm. In addition, Transmission Electron Microscopy (TEM) 
analysis was performed on carboxyl-fentanyl nanoMIPs and results are 
showed in the Figure S2 using JEOL 1400 transmission electron mi-
croscope (JEOL, USA) with an accelerating voltage of 80 kV. Images 
were taken using a Megaview III digital camera. The nanoMIPs show a 
comparable size to the one detected by SEM (89.9 ± 17.9 nm). This is 
slightly lower than DLS as DLS estimates the hydrodynamic size of the 
particle which tends to be larger than the dry size of a polymeric particle 
(Bootz et al., 2004). This is because the nanoMIPs presented in this work 
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are hydrogels (with low crosslinking degree) which – by definition – 
would swell in solution, hence leading to an apparent larger size when 
measured by DLS. 
2.2. Temperature calibration 
At the phase matching condition, the attenuation band of an LPG 
sensor at a specific cladding mode initially appears as one broad band 
which continues to grow and finally splits into two coupled bands as 
refractive index continues to increase (Xuewen et al., 2002). The 
coupled dual bands will shift in opposite directions in response to 
external perturbations such as temperature or refractive index changes. 
The wavelength separation of the dual bands is therefore used to mea-
sure parameters providing a higher sensitivity than a single band. Fig.S.3 
demonstrates response of the LPG array sensor to temperature. Both LPG 
sensors (reference and detection) exhibit a linear increase as tempera-
ture increases from 20 ◦C to 27 ◦C with sensitivity of 0.49 nm/◦C and 
0.99 nm/◦C, respectively. The coupled dual bands of the two LPGs 
correspond to the cladding mode LP019 which is determined by simu-
lation with software Optigrating with a model built close to the fabricated 
sensor (result shown in the supplementary data, Fig.S.4). The detection 
LPG (nanoMIPs coated) shows a higher sensitivity that is twice of that of 
the reference LPG (bare). The higher sensitivity is because the detection 
LPG with a higher grating period is closer to its phase matching turning 
point than that of reference LPG, where the highest sensitivity is ach-
ieved (Xuewen et al., 2002). The contribution of coated nanoMIPs to the 
high thermal sensitivity of the detection LPG is considered less of 
importance in this case due to the high temperature stability of MIPs 
(Refaat et al., 2019). To subtract the temperature effect from the 
detection LPG sensor, the following equation can be applied: 
Δλ=Δλdet − 2 × Δλref (2)  
Where Δλ is the wavelength shift induced by the binding, Δλdet and Δλref 
is the wavelength shift of the detection LPG and reference LPG, 
respectively. 
2.3. Sensor measurement 
A bare LPG exhibits a wavelength shift of about 0.2 nm when 
immersed into 1000 ng/mL of the prepared carboxyl-fentanyl solution. 
The magnitude of wavelength shift is less than its noise level (~0.3 nm) 
Fig. 1. SEM image of nanoMIPs immobilised on the surface of the optical fibre. 
Scale bar = 100 nm. 
Fig. 2. (a) Transmission spectra of the LPG array in air before and after nanoMIPs coating; (b) Transmission spectra of the LPG array in different concentrations of 
carboxyl-fentanyl solution. (c) Dynamic response of the LPG array to different concentrations of carboxyl-fentanyl; signal is taken as wavelength separation of the 
dual bands of LP019. (d) Wavelength shift of LP019 as a function of carboxyl-fentanyl concentration after subtracting temperature contribution. 
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in a blank sample (solvent only), suggesting that the contribution of bulk 
refractive index of the fentanyl solution is negligible (result not shown). 
Fig. 2a illustrates the transmission spectrum of the LPG array at cladding 
mode of LP019 before and after attaching nanoMIPs (surrounding me-
dium is air). It is clear that the reference LPG (LPG-Ref) shows a negli-
gible change in its attenuation bands. The attenuation band of the 
detection LPG (LPG-Det) in the same cladding mode, on the other hand, 
shows a further development with the band at phase matching condition 
separating further indicating the attachment of nanoMIP as a result of 
the increase of surface RI and effective thickness of the fibre. The 
transmission spectrum of the LPG array in different concentrations of 
carboxyl-fentanyl solution is shown in Fig. 2b, in which the dual bands 
of the detection LPG exhibits an opposite wavelength shift in response to 
binding of carboxyl-fentanyl, as a result of increase of surface refractive 
index. The reference LPG, on the other hand, remains relatively stable as 
carboxyl-fentanyl concentration increases. 
The wavelength separation of the dual bands of the two LPGs is 
illustrated in Fig. 2c as a function of time during the measurement. There 
is a clear step change for the detection LPG (red colour) that follows the 
step increase of the concentration of carboxyl-fentanyl in solution from 
0 to 1000 ng/mL. The reference LPG (purple colour) also shows certain 
levels of wavelength change most likely due to temperature fluctuation 
between solutions. Fig. 2d shows the wavelength shift of the detection 
LPG after subtracting the temperature effect from the reference LPG by 
using Eq. (2). The wavelength shift is thus the response solely to binding 
of carboxyl-fentanyl. The wavelength change exhibits a gradual satu-
ration as the increase of the concentration indicating the gradual satu-
ration of the capture sites. The data fits well with the Langmuir 
adsorption isotherm with a coefficient of determination value R2 =
0.9629 (p < 0.05). The binding constant and maximum wavelength shift 
are determined as 0.0053 (ng/mL)-1 (2.03 μM-1) and 5.4 nm, respec-
tively. The minimum detectable concentration of carboxyl-fentanyl in 
the experiment is 50 ng/mL which corresponds to a wavelength shift of 
1.20 ± 0.2 nm. The biggest wavelength shift is observed as 4.95 ± 0.3 
nm at the concentration of 1000 ng/mL. Compared to the nanoMIPs 
functionalised sensor, the bare sensor (second LPG array) which is used 
as a baseline sensor exhibits no shift in its wavelength after compen-
sating temperature effect (black point in Fig. 2d). This result also sug-
gests that wavelength shift in the nanoMIPs functionalised sensor is 
caused by surface refractive index changes induced by carboxyl-fentanyl 
binding rather than temperature or bulk refractive index. The concept of 
bulk refractive index and surface refractive index is explained in depth 
by Chiavaioli.et al (Chiavaioli et al., 2017). The control sensor that was 
coated with control polymer particles exhibits a small increment in 
wavelength (~0.7 nm) at high concentration, indicating that there is a 
certain level of non-specific adsorption but the signal is far less than in 
the imprinted sensor. 
2.4. Cross-selectivity test 
Selectivity is particularly important for biosensors as clinical samples 
such as blood serum usually contain a variety of substances including 
large molecules such as proteins or small molecules such as glucose. 
High selectivity ensures a biosensor responds to the presence of inter-
ferents to a lesser extent compared to the target analytes. Fig. 3a shows 
the developed carboxyl-fentanyl sensor response to drugs typically 
found in blood samples of fentanyl and fentanyl analogues overdose 
victims, such as morphine, and cocaine (Pearson et al., 2015; Gill et al., 
2013). Albumin is the most abundant protein presents in human blood 
serum. The cross-selectivity of the developed carboxyl-fentanyl sensor is 
tested separately against BSA and glucose solution (1 μg/mL in distilled 
water) which are the two most abundant interfering substances present 
in blood serum. The result shows that the sensor does not respond to the 
presence of glucose and only about half nanometer wavelength shift in 
the presence of BSA (Fig. 3b). The wavelength shift is likely to be caused 
by non-specific adsorption of BSA on the nanoMIPs particles. 
Remarkably, the sensor does show greater selectivity for the two small 
molecules cocaine and morphine and, even more interestingly, is able to 
distinguish between very structurally similar compounds as fentanyl and 
carboxyl fentanyl. 
Selectivity over carboxyl-fentanyl is likely due to the monomers 
capability of arranging around the template during the imprinting pro-
cess and forming a specific binding site by means of not covalent in-
teractions. The monomers part of the polymerisation mixture capable of 
hydrogen bonding (e.g. methacrylic acid) can interact with the carbonyl 
of carboxyl-fentanyl during the imprinting process, thus creating a 
specific interaction. Therefore, the resulting MIP would be able to 
recognise that carbonyl group imprinted in the first place. The LPG of 
the nanoMIPs coated grating operates at the phase-matching condition 
providing high RI sensitivity to measure small RI change induced by 
carboxyl-fentanyl binding. A reference LPG within the array enables 
temperature compensation during measurements. This approach ad-
dresses a common issue of these type of sensors that is temperature 
cross-sensitivity, thus strict temperature control is no longer needed. 
Resolution for temperature measurement of the detection and reference 
LPG are 0.34 ◦C and 0.17 ◦C, respectively. This suggests that the tem-
perature fluctuation within 0.34 ◦C will not be removed from the 
detection LPG (equivalent wavelength shift is ~0.33 nm) due to the 
lower temperature sensitivity of the detection LPG. Therefore, the res-
olution of the LPG array sensor for detection of carboxyl-fentanyl is 
defined as 0.33 nm which tolerates the temperature fluctuation despite 
the spectral resolution of the spectrometer being 0.17 nm. 
The MIPs functionalised sensor is further deployed to detect 
carboxyl-fentanyl in human serum. The results demonstrate that the 
sensor responds to the presence of carboxyl-fentanyl in serum with an 
increase in wavelength separation with increase of carboxyl-fentanyl 
concentration (Fig. S6a). The increase of wavelength separation in 
PBS washing solution after each exposure in serum sample also confirms 
the attachment of carboxyl-fentanyl on the sensor surface. In contrast, 
the sensor’s subsequent exposure to a blank serum sample shows no 
change at each exposure (Fig. S6b). 
2.5. Comparison with existing method 
A comparison of different approaches is shown in Table 1. Although 
some of the laboratory based instruments provide better performance, 
they are impractical for real time routine forensics due to size; longer 
testing times; expense of equipment and operator training. The optical 
fibre nanoMIP sensor provides the potential for a new point of use 
platform that can be rapidly adapted for different molecules and mul-
tiplexed sensing. 
One of the most concerning issues in the forensic field is the lack of 
drug detection due to a large time window between the discovery of a 
new designer drug and its routine detection in hospitals and police 
stations (Harper et al., 2017). The short production time of nanoMIPs 
(average of 4 weeks synthesis and characterisation), combined with its 
flexibility to imprint many types of molecules, is a considerable 
Fig. 3. (a) Real-time response of the developed sensor to three different drugs 
(fentanyl, morphine and cocaine in methanol), at a concentration of 1 μg/mL 
(b) Sensor response to different substances (1 μg/mL). 
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advantage over the techniques previously described. NanoMIPs can be 
manufactured and integrated in the device reported in a short period of 
time still maintaining a high level of sensitivity, as demonstrated in 
Section 2.3. 
The integration of the flexibility of nanoMIPs to optical fibre tech-
nology provides the basis for producing an interchangeable device for 
different detection purposes. The device, currently demosnarted to 
measure one compound at the time, could easily be upgraded to a 
multiplexing platform by functionalising more than one optical fibre, or 
LPG, with nanoMIPs imprinted for different molecules, analogues of the 
same drug, as well as structurally different molecules (e.g. peptides or 
proteins), achieving the simultaneous monitoring of a multitude of pa-
rameters for a more complete diagnostic picture, previously identified as 
the ultimate goal of the diagnostic field (Tighe et al., 2015). 
3. Experimental 
Traditional imprinting methods typically require several days due to 
the need for multiple time-consuming purification steps (Cirillo et al., 
2009). An innovative solid-phase synthesis which overcomes these 
problems is becoming more popular, as it reduces the speed of 
manufacturing and requires very little post-synthesis purification 
(Guerreiro et al., 2009). This approach can be successfully applied in 
both organic (UV-triggered process) and water (persulfate-initiated 
polymerisation) solutions; aqueous polymerisations have shown to be 
more efficient in imprinting peptides and proteins (Poma et al., 2013, 
2014), whereas organic ones work better for small molecules (Moczko 
et al., 2013; Basozabal et al., 2014). Indeed, the organic polymerisation 
was chosen for the imprinting of carboxyl-fentanyl. The organic pho-
topolymerisation used in this work employs N,N′-diethyldithiocarbamic 
acid benzyl ester as initiator. This kind of initiator can act as an initiator, 
transfer agent and terminator (Iniferter). Iniferters generate one radical 
(dithiocarbamyl) after the decomposition step which can terminate the 
growth of the polymer chains in solution, reforming the initial C–S bond. 
Therefore, the product formed after termination can further generate a 
new propagating radical upon application of the stimulus triggering the 
polymerisation (Lim et al., 2003). In this way, sequential polymerisa-
tions with other monomers can be re-initiated, in order to tailor prop-
erties or functionalities of the synthesised particles (Guerreiro et al., 
2009) (Takayuki, 2000). Moreover, in contrast to conventional radical 
polymerisation, the iniferter-based living polymerisation proceeds at 
low rate without auto acceleration phenomena, allowing a better control 
over some parameters such as the polymer chain length and the particle 
size (Kannurpatti et al., 1996). 
3.1. Silanization of solid-phase support 
A solid-phase approach described by Canfarotta et al. (2016) was 
adapted for nanoMIPs synthesis. The surface of glass beads (100 g) was 
activated by boiling in sodium hydroxide (4 M, 80 mL) for 15 min prior 
to washing with water (5 × 2 L). The beads were subsequently placed in 
Table 1 
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a solution of sulphuric acid (50%, 40 mL) for 60 min before again being 
washed with water (3 × 2 L) and incubated in buffer (PBS 10 mM, 400 
mL) for 5 min. Further water washes (10 × 2 L) were performed to 
ensure the final pH was between 6 and 8. The solid phase was dried by 
washing with acetone (3 × 240 mL) and placing under vacuum, before 
leaving in an oven (150 ◦C) for 60 min. Activated beads were incubated 
in a solution of toluene (40 mL) with (3-aminopropyl)triethoxysilane 
(1.172 mL,5.418 mmol) and 1,2-bis(triethoxysilyl)ethane (0.96 mL, 
2.59 mmol) overnight at 80 ◦C. Beads were subsequently washed with 
toluene (3 × 450 mL), ethanol (3 × 450 mL), and acetone (5 × 450 mL) 
to remove any residual silane, before drying under vacuum and further 
oven drying for 60 min at 150 ◦C. 
The presence of NH2 groups was assessed using ninhydrin test. A 
sample of dry glass beads (1 × 3 g of glass beads) was incubated with a 
ninhydrin solution (2 ml, 6 mM in EtOH) for 180 min, at 60 ◦C. The 
absorbance was then read at 580 ± 3 nm. A surface coverage of 0.967 
μmol NH2 per gram of glass beads was achieved. 
EDC/NHS coupling was used to covalently attach the template of 
interest to the surface of the glass beads. Due to the lack of functional 
groups available in the native structure of fentanyl for coupling to the 
solid support, an analogue containing a carboxyl group (Fig.S.5) was 
instead used, allowing immobilisation to be performed using a 
straightforward EDC/NHS coupling strategy. 
3.1.1. Carboxyl-fentanyl synthesis 
The relevant chemical reactions involved in synthesis of carboxyl- 
fentanyl are illustrated in Fig. 4 and the process is described in detail 
below. 
3.1.1.1. N-[1-(2-phenethyl)-4-piperidinyl]aniline (2). This compound 
was prepared following the method reported by Valdez et al. (2014): 
Aniline (2.06 g 22 mmol) and dichloromethane (60 mL) were added to a 
3-necked round-bottomed flask equipped with stopper, CaCl2 guard tube 
and a dropping funnel. The contents were stirred and cooled (ice-bath) 
and acetic acid (1.25 mL) was added dropwise to the mixture. This was 
followed by a further 10 mL of dichloromethane to rinse the dropping 
funnel before the addition of a solution of N-phenethylpiperidin-4-one 
(1) (4.5 g, 22 mmol) in dichloromethane (15 mL). When addition was 
complete, sodium triacetoxyborohydride (7.025 g, 33 mmol) was added 
in small portions to the mixture. When addition was complete, the ice 
bath was removed and the mixture stirred at room temperature over-
night. After the overnight stirring, methanol (25 mL) was added to 
destroy any excess of reducing agent and the reaction mixture was 
transferred to a 1 L separating funnel and the acid neutralised by the 
addition of saturated NaHCO3 solution (appox 200 mL). When CO2 
evolution had ceased, the clear yellow lower organic layer was separated 
and the aqueous layer was extracted with more CH2Cl2 (10 mL). After 
setting aside the aqueous layer, the combined organics were returned to 
the separating funnel and washed with brine (3 × 25 mL) and the or-
ganics were dried (MgSO4), filtered and evaporated to give a solid res-
idue. This was recrystallized from hexanes to yield 4.1413g (67%) of an 
off-white solid. The NMR (1H and 13C) was identical to the literature 
spectra (Valdez et al., 2014) with no impurities. Subsequent concen-
tration of the mother liquour and recrystallization gave a second batch 
of 0.4013g, giving an overall yield of 4.5g (73%). 1H NMR CDCl3 (500 
MHz) 7.28–7.31 (m, 2H), 7.20–7.22 (m, 3H), 7.17 (t, J = 7Hz, 2H), 6.68 
(t, J = 7 Hz, 1H), 6.60 (d J = 8Hz, 2H), 3.52 (br, 1H), 3.32 (m, 1H), 
2.80–2.84 (m, 2H), 2.60–2.63 (m, 2H), 2.21 (t, J = 11 Hz), 2.09 (d, J =
12 Hz, 2H), 1.51 (m, 2H). 13C NMR CDCl3 (125.77 MHz) 147.12, 140.43 
(2 × quat.), 129.37, 128.74, 128.44, 126.09, 117.23, 113.26 (6 × aro-
matic CH), 60.73, 52.53 (2 × CH2), 49.95 (CH), 33.97, 32.63 (2 × CH2). 
3.1.1.2. Methyl 4-oxo-4-{phenyl-[1-(2-phenylethyl)-4-piperidinyl] amino} 
butanoate (3). This compound was prepared by the method of Bremer 
et al. (2016) based on the synthesis of the homologous pentanoate de-
rivative. In a 3-necked flask fitted with stopper, CaCl2 guard tube and 
addition funnel: N-[1-(2-phenethyl)-4-piperidinyl]aniline (2 g, 7.14 
mmol) was dissolved in dry dichloromethane (50 mL) to which was 
added pyridine (1.15 mL, 14.2 mmol). The solution was cooled in an 
ice-bath before the dropwise addition, with stirring, of methyl succinyl 
chloride (1.03 g, 7.8 mmol) in dry dichloromethane (20 mL). After 
addition of the acyl chloride, the reaction was stirred at 0 ◦C for 5 min 
before removing from the ice bath and stirring for 4h at room temper-
ature. The reaction was quenched by the addition of a saturated aqueous 
solution of NaHCO3 and the contents of the flask transferred to a 
separating funnel. The dichloromethane layer was separated and the 
aqueous layer extracted with ethyl acetate (3 × 25 mL). The combined 
organic extracts were washed once with brine, separated, dried (MgSO4) 
and evaporated to give a pale yellow oil. The product was obtained as 
colourless crystals from hexanes, 1.88 g, (67%). 1H NMR CDCl3 (400 
MHz) 7.35–7.43 (m, 3H), 7.23–7.27 (m, 2H), 7.12–7.19 (m, 5H), 3.66 (s, 
3H), 3.0–3.02 (m, 2H), 2.71–2.75 (m, 2H), 2.51–2.58 (m, 4H), 2.20 (t, J 
= 6.5 Hz, 2H), 2.15 (d,t, J = 2 Hz, J = 12 Hz, 2H), 1.79–1.83 (m, 2H), 
1.44 (tt, J = 4 Hz, J = 12 Hz, 2H). 13C NMR CDCl3 (100.62 MHz) 
173.57, 171.01 (2 × carbonyl), 140.15, 138.43 (2 × quat), 130.45, 
129.44, 128.63, 128.49, 128.39, 126.04 (6 × aromatic CH), 60.35, 
53.00 (2 × CH2), 52.44, 51.65, 33.71, 30.40, 30.10, 29.21 (4 × CH2). 
3.1.1.3. 4-oxo-4-{phenyl-[1-(2-phenylethyl)-4-piperidinyl] amino} buta-
noic acid (4) (hydrolysis method) (carboxyl-fentanyl). The hydrolysis of 
(3) was also carried out according to Bremer (Bremer et al., 2016). The 
methyl ester (1.5 g, 3.8 mmol) was dissolved in methanol (30 mL) and 
aqueous LiOH, 1M, (7.6 mL) was added and the mixture stirred at room 
temperature overnight. The mixture was washed with hexane, then 
acidified with HCl. The acidified solution was extracted with ethyl ac-
etate (3 × 25 mL) and the combined organics dried (MgSO4) and 
evaporated to give a colourless foamy solid (0.84 g). Attempts to crys-
tallise the products were unsuccessful despite reports of crystallisation 
from ethyl acetate (Vardanyan et al., 2011), methanol (Nichol et al., 
2010), or a benzene-hexane mixture (Henderson et al., 1975). As crys-
tallisation might be inhibited by an impurity, the product was purified 
by column chromatography on silica gel, from 5% MeOH:CH2Cl2 to 10% 
MeOH:CH2Cl2. A pure fraction was obtained by combining fractions 
containing the lower of three spots (tlc, silica, 1:9 MeOH:CH2Cl2). The 
pure fraction (0.46 g) was also obtained as an amorphous solid. (32 %). 
Fig. 4. Schematic illustration of synthesis of carboxyl-fentanyl, N-[1-(2-phe-
nethyl)-4-piperidinyl]aniline (2) was prepared with the addition of aniline and 
dichloromethane to N-phenethylpiperidin-4-one (1). Methyl 4-oxo-4-{phenyl-[1- 
(2-phenylethyl)-4-piperidinyl] amino} butanoate (3),was prepared by the addition 
of CaCl2 and N-[1-(2-phenethyl)-4-piperidinyl]aniline in dry dichloromethane 
to which was added pyridine. For the synthesis of 4-oxo-4-{phenyl-[1-(2-phe-
nylethyl)-4-piperidinyl] amino} butanoic acid (4) (carboxyl-fentanyl) the hydro-
lysis of (3) was carried out. The pure fraction was also obtained as an 
amorphous solid. 
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1H NMR CD3OD (400 MHz) 7.57–7.49 (m, 3H), 7.36–7.32 (m, 4H), 
7.28–7.25 (m, 3H), 4.80 (tt, J = 12.9 Hz, 4.3 Hz, 1H) 3.65 (br d, J – 12.5 
Hz, 2H), 3.30–3.25 (m, 2H), 3.20–3.13 (m, 2H), 3.03–2.98 (m, 2H), 2.54 
(t, J = 6.5 Hz, 2H), 2.23 (t, J = 6.5 Hz, 2H), 2.15 (br d, J = 13.7 Hz, 2H), 
1.79–1.68 (m, 2H). 13C NMR CDCl3 (125.77 MHz) 175.71, 172.21, 
136.21, 130.08, 129.70, 129.34, 128.93, 128.77, 127.23, 53.44, 51.86, 
50.65, 50.56, 30.30, 29.95, 29.34, 27.49. 
3.1.2. Carboxyl-fentanyl immobilisation on glass beads 
Silanised glass beads (60 g) were incubated with the solution of EDC/ 
NHS/template in PBS (24 mL,10 mM) at 0.1 mg/mL of carboxyl-fentanyl 
(6.29 μmol). Prior to the incubation with glass beads, the –COOH groups 
of the carboxyl-fentanyl are activated by adding EDC (10 times molar 
excess, 62.9 μmol) and NHS (15 times molar excess, 94.5 μmol) to a 
solution of MES buffer (10 mM, pH 5–6) for 10 min. The activated 
template solution is then added to glass beads in PBS and incubated at 
room temperature for 4h prior to washing with water (10 × 24 mL), then 
acetone (3 × 24 mL) and eventually dried under vacuum. 
3.1.3. NanoMIPs synthesis 
The process of synthesising nanoMIPs is illustrated in Fig. 5. Poly-
merisation mixture consisting of MAA(2.15 g, 24.97 mmol), HEMA 
(0.435 g, 3.34 mmol), styrene (0.174 g, 1.67 mmol), EGDMA (3.24 g, 
16.35 mmol), TRIM (3.24 g, 9.57 mmol) PEMPT (0.18 g, 0.37 mmol) N, 
N-diethyldithiocarbamic acid benzyl ester (0.75 g, 3.13 mmol) tri-
fluoroethyl methacrylate (0.515 g, 3.06 mmol), fluorescein-N-acrylate 
(0.025 g, mmol) was prepared in ACN (12 mL) and purged with nitrogen 
for 17 min at 0 ◦C under exclusion of light. Following this, the poly-
merisation mixture was added to the derivatised beads (30 g) (Fig. 5a) 
and polymerisation initiated using UV light for 1 min and 45 s (Fig. 5b). 
The beads were subsequently washed with ACN (10 × 30 mL) at 0 ◦C to 
remove unreacted monomer and low-affinity polymer before eluting 
high-affinity nanoMIPs with hot ACN (100 mL, 60 ◦C) (Fig. 5c and d). 
Control nanoMIPs were produced using the same protocol as the 
described above, with a small model peptide used as target molecule. It 
should be noted that it is not possible to produce NIPs with the same size 
(and hence surface area) by solid-phase imprinting: given the MIPs are 
produced around the template immobilised on the solid-phase, pro-
ducing NIPs without any template immobilised on the solid-phase is not 
possible. In order to address this and account for any potential non- 
specific adsorption of the template on the MIPs, a control MIP was 
produced, which is essentially a polymer with identical composition to 
the MIPs, only imprinted for a non-related molecule, such that the MIPs 
can be collected after the cold washes. In this case, the “template” acts as 
an “anchor” such that control MIPs can be harvested – following the 
exact same protocol used for the target MIPs. 
Non-specific binding would derive from the outer polymer layer on 
the MIP. So, as long as the polymer composition between target and 
control MIPs is kept constant and the production process is the same, the 
control MIP would be the equivalent of a NIP and would therefore give 
an indication of any potential non-specific binding. 
3.1.4. Post-synthesis characterisation 
After collection, the high-affinity nanoMIPs were evaporated down 
to 2 mL, 8 mL HPLC water added and dialysed overnight using Snake-
Skin 10 K MWCO dialysis membranes. Nanoparticle size was determined 
by DLS using a Zetasizer Nano (Nano-S, Malvern Instruments, UK). Prior 
to DLS measurements, samples were subjected to sonication for 2 min, 
vortexed for 30 min, and measurements performed at 25 ◦C. 
3.2. Functionalisation of the LPG sensor 
An LPG array with two LPGs located closely (1.5 cm length each with 
~1 cm gap in between) on a single fibre is fabricated through UV irra-
diation on a boron-doped photo-sensitive optical fibre (PS750, Fibre-
core, UK). A frequency quadrupled Nd:YAG laser emitting at 266 nm 
(Continuum minilite I) is the laser source used to inscribe a periodic 
grating structure on the optical fibre through custom made steel alloy 
amplitude masks. The two LPGs having grating period of 111.5 μm and 
110.0 μm are used as detection and reference LPG respectively. 
The functionalisation of LPG is conducted by immobilizing nanoMIPs 
on the LPG sensor surface. This process involves two steps as illustrated 
in Fig. 6a: 
Silanization of LPG surface: the detection LPG is initially treated with 
1 wt% ethanolic KOH solution (ethanol/water = 3:2. v/v) for 30 min to 
etch the surface with –OH group. After washing with deionized water 
(15 MΩ cm) and drying with N2, the LPG is then immersed into freshly 
prepared APTES (2% v/v, APTES in ethanol) for 20 min. After washing 
with ethanol and water, the LPG is placed into a pre-heated oven at a 
Fig. 5. Schematic representation of solid-phase synthesis of carboxyl-fentanyl 
imprinted nanoMIPs. 
Fig. 6. (a) Surface functionalisation process involved in the nanoMIPs coating; 
(b) Schematic illustration of an LPG array; (c) Flow system for measuring 
of analytes. 
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temperature of 120 ◦C for 20 min to condense the chemical bonds (-Si-O- 
Si-) and remove water molecules from the surface. 
Fentanyl nanoMIPs immobilisation: a 150 μL aliquot of the sonicated 
nanoMIPs solution in water is added into 400 μL of MES buffer (0.1 M, 
pH = 5.6) containing 0.4 mg of EDC and 1 mg of NHS, and stirred 15 
min at room temperature (22 ◦C). Subsequently, 175 μL of carbonate 
buffer (pH = 11) are added to the solution to increase the pH to about 7; 
the prepared LPG is then incubated overnight at room temperature. 
Afterwards, the LPG is washed with distilled water to remove loosely 
bound nanoMIPs, and then immersed into a carbonate buffer (pH = 9.2) 
for 2 h to hydrolyse remaining NHS-esters and recover the original 
–COOH groups. 
Control nanoMIPs were immobilised on the LPG sensor by using the 
same protocol used for carboxyl-fentanyl nanoMIPs. 
3.3. Measurement procedure with the developed OFS 
Different concentrations of carboxyl-fentanyl solutions are prepared 
by dissolving carboxyl-fentanyl into a solvent that contains a mixture of 
methanol and distilled water in a ratio of 1:3 v/v with a concentration 
range from 0 to 1000 ng/mL. 
For the measurement, the LPG array (shown in Fig. 6b) is subse-
quently exposed to different concentrations of the prepared carboxyl- 
fentanyl solution for 20 min, followed by washing with distilled water 
between each measurement. Meanwhile, a second LPG array with the 
same grating periods and transmission spectrum to the first array 
without nanoMIPs coating is used as a baseline sensor. The second LPG 
array was immersed into different concentrations of the same carboxyl- 
fentanyl solution to evaluate the effect of bulk refractive index of the 
testing solution to the response of the LPG array. A halogen light source 
(Ocean Optics, HL-2000, UK) and a CCD spectrometer (Ocean Optics, 
HR4000, UK) are employed for launching light into the fibre and 
detecting the transmission spectrum of the LPGs. Furthermore, a closed- 
loop microfluidic flow system (Fig. 6c) is adapted for testing the sensor 
response. For selectivity tests, popular opioid drugs including fentanyl 
and morphine, and cocaine with the same concentration (1000 ng/mL, 
in methanol) were used. An in-house made silicone flow cell for hosting 
LPG is fabricated by casting silicone elastomer (Sylgard® 184) into a 3D 
printed mould and curing in ambient temperature for two days. The 
channel in which the LPG lays has an inner diameter of ~1 mm that 
allows liquid to flow through. A peristaltic pump circulates drug samples 
to the flow cell at a speed of 0.4 mL/min that produces an optimal liquid 
flow of ~8 mm/s inside of the flow channel which is experimentally 
defined by balancing diffusion limit and shear stress as reported in 
(Huang et al., 2014). 
To demonstrate the applicability of such a sensor in real sample, 
human serum containing different concentrations of carboxyl-fentanyl 
are prepared by dissolving carboxyl-fentanyl in methanol and further 
mixing with human serum (the volume ratio of serum to methanol is 
100:1). The sensor is subsequently exposed to the prepared sample from 
low to high concentrations followed by washing with PBS buffer. 
4. Conclusion 
NanoMIPs imprinted with carboxyl-fentanyl were successfully syn-
thesised and collected via a solid-phase approach. The nanoMIPs 
(average hydrodynamic diameter of 171 ± 2 nm) are successfully 
deposited on the surface of an LPG array optical fibre sensor via EDC/ 
NHS coupling. 
The LPG array with selected grating periods is fabricated through UV 
irradiation to provide high RI sensitivity. Experimental results demon-
strate that the synthesised nanoMIPs have the capability of rebinding 
carboxyl-fentanyl and producing a detectable refractive index change 
which is indicated via a wavelength shift in the LPG array. Interestingly, 
the developed nanoMIPs-LPG sensor does not respond to blood inter-
ferents (BSA and glucose) and similarly sized small molecules (morphine 
and cocaine), and most notably shows much higher selectivity for its 
structurally similar compound fentanyl. Every year new psychoactive 
substance analogues are brought to the market, often with very small 
structural changes from the lead compound. The rapid development of 
these analogues challenges diagnostics to keep pace, therefore making 
sensor fabrication quickly is pivotal. The results from this work 
demonstrate the manufacture of a versatile sensor showing low cross- 
reactivity with analogues and interfering compounds, and with little 
development time required. 
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